Fund Holdings — TCG Crossover Management, LLC

Total Portfolio Value:
$901.70M
Total Bought:
$106.93M
Total Sold:
$49.88M
Net Transaction:
+$57.05M
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
Structure Therapeutics IncADRS1,502,7472,109,584+606,837$75.77M$85.99M9.54%+$10.22M
Inhibrx,incCOMM1,750,3871,750,3870$32.12M$66.51M7.38%+$34.40M
Icosavax IncCOMM3,703,7043,703,7040$28.70M$58.37M6.47%+$29.67M
AN2 Therapeutics, Inc.COMM2,678,2092,678,2090$43.07M$54.88M6.09%+$11.81M
Rayzebio, Inc.COMM869,908869,9080$19.31M$54.08M6.00%+$34.77M
Aerovate Therapeutics IncCOMM2,201,2742,201,2740$29.87M$49.81M5.52%+$19.94M
Geron CorporationCOMM(GERN)23,375,83923,375,8390$49.56M$49.32M5.47%-$233.8K
Savara Inc.COMM(SVRA)10,000,00010,000,0000$37.80M$47.00M5.21%+$9.20M
Gracell Biotechnologies Inc.ADRS3,038,8894,514,786+1,475,897$8.75M$45.33M5.03%+$36.58M
Madrigal Pharmaceuticals, Inc.COMM(MDGL)179,917179,9170$26.28M$41.63M4.62%+$15.35M
Kalvista Pharmaceuticals, IncCOMM3,395,4953,395,4950$32.70M$41.59M4.61%+$8.90M
Silence Therapeutics plcADRS(SLN)2,104,8752,104,8750$20.67M$36.56M4.05%+$15.89M
COMPASS Pathways plcADRS(CMPS)3,858,0003,858,0000$28.55M$33.76M3.74%+$5.21M
Cogent Biosciences, Inc.COMM(COGT)5,631,0425,631,0420$54.90M$33.11M3.67%-$21.79M
Tyra Biosciences, Inc.COMM(TYRA)1,989,1031,989,1030$27.39M$27.55M3.06%+$159.1K
Tourmaline Bio IncCOMM01,007,902+1,007,902$0$26.39M2.93%+$26.39M
Tarsus Pharmaceuticals, Inc.COMM(TARS)1,142,8571,142,8570$20.31M$23.14M2.57%+$2.83M
Dyne Therapeutics, Inc.COMM(DYN)1,650,1501,650,1500$14.79M$21.95M2.43%+$7.16M
Kura Oncology, Inc.COMM(KURA)1,423,6421,423,6420$12.98M$20.47M2.27%+$7.49M
Centessa Pharmaceuticals PlcCOMM2,040,8162,040,8160$13.20M$16.24M1.80%+$3.04M
Vistagen Therapeutics, Inc.COMM(VTGN)02,676,580+2,676,580$0$13.76M1.53%+$13.76M
ABIVAX Société AnonymeCOMM(ABVX)01,100,000+1,100,000$0$11.77M1.31%+$11.77M
Cabaletta Bio, Inc.COMM(CABA)486,795486,7950$7.41M$11.05M1.23%+$3.64M
Entrada Therapeutics, Inc.COMM(TRDA)584,955584,9550$9.24M$8.83M0.98%-$415.3K
Nurix Therapeutics, Inc.COMM(NRIX)0717,654+717,654$0$7.41M0.82%+$7.41M
C4 Therapeutics, Inc.COMM(CCCC)1,276,5741,276,5740$2.37M$7.21M0.80%+$4.84M
Taysha Gene Therapies, Inc.COMM(TSHA)11,111,1112,912,861-8,198,250$35.11M$5.16M0.57%-$29.96M
Ventyx Biosciences, IncCOMM815,724815,7240$28.33M$2.01M0.22%-$26.32M
Kodiak Sciences Inc.COMM(KOD)0267,941+267,941$0$814.5K0.09%+$814.5K
IMMUNOVANT, INCCOMM(IMVT)334,8530-334,853$12.86M$0—-$12.86M
MERUS N.V.COMM300,0000-300,000$7.07M$0—-$7.07M
Page 1 of 1
TCG Crossover Management, LLC — 13F Holdings — Q4 2023 | TickerTrail